Medicine Man Technologies, Inc. - Understand $shwz stock

$SHWZ Market Cap: $7.825 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$172.4M

TTM

Gross Margin

44.38%

TTM

Net Earnings

-$36.77M

TTM

Current Assets

$53.67M

Q4 2023

Current Liabilities

$55.46M

Q4 2023

Current Ratio

96.77%

Q4 2023

Total Assets

$358.1M

Q4 2023

Total Liabilities

$238.9M

Q4 2023

Book Value

$119.3M

Q4 2023

Cash

$19.25M

Q4 2023

P/E

-0.2128

Nov 29, 2024 EST

Free Cash Flow

$1.585M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$172.4M	$159.4M	$108.4M	$24.00M	$12.40M	$9.443M	$3.530M	$631.5K	$835.8K	$300.0K
YoY Change	8.2%	47.0%	351.74%	93.54%	31.33%	167.53%	458.96%	-24.45%	178.59%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$172.4M	$159.4M	$108.4M	$24.00M	$12.40M	$9.443M	$3.530M	$631.5K	$835.8K	$300.0K
Cost Of Revenue	$96.42M	$74.35M	$59.07M	$17.23M	$7.616M	$2.578M	$1.302M	$462.2K	$209.8K
Gross Profit	$76.02M	$85.03M	$49.35M	$6.774M	$4.785M	$6.865M	$2.227M	$169.3K	$626.0K
Gross Profit Margin	44.09%	53.35%	45.52%	28.23%	38.58%	72.7%	63.1%	26.81%	74.9%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Selling, General & Admin	$39.92M	$29.40M	$38.94M	$29.68M	$16.47M	$4.695M	$7.313M	$1.321M	$535.9K	$200.0K
YoY Change	35.78%	-24.51%	31.23%	80.23%	250.74%	-35.8%	453.44%	146.58%	167.94%
% of Gross Profit	52.51%	34.57%	78.91%	438.08%	344.14%	68.39%	328.33%	780.58%	85.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.93M	$11.01M	$8.577M	$476.6K	$61.71K	$81.96K	$63.74K	$17.37K	$6.620K	$0.00
YoY Change	90.09%	28.4%	1699.63%	672.31%	-24.71%	28.58%	266.95%	162.39%
% of Gross Profit	27.54%	12.95%	17.38%	7.04%	1.29%	1.19%	2.86%	10.26%	1.06%
Operating Expenses	$72.73M	$72.17M	$38.94M	$29.68M	$21.87M	$4.695M	$7.313M	$1.321M	$535.9K	$300.0K
YoY Change	0.78%	85.33%	31.23%	35.72%	365.77%	-35.8%	453.44%	146.58%	78.62%
Operating Profit	$3.289M	$12.85M	$10.41M	-$22.90M	-$17.08M	$2.170M	-$5.086M	-$1.152M	$90.16K
YoY Change	-74.42%	23.5%	-145.45%	34.08%	-887.06%	-142.68%	341.43%	-1377.83%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Interest Expense	-$16.20M	-$11.76M	$8.264M	$1.092M	-$325.6K	-$433.4K	-$75.18K	-$312.2K	$8.070K	$0.00
YoY Change	37.68%	-242.36%	656.87%	-435.33%	-24.87%	476.47%	-75.92%	-3968.53%
% of Operating Profit	-492.51%	-91.52%	79.39%			-19.97%			8.95%
Other Income/Expense, Net	-$18.10M	-$16.42M	$0.00	$32.62K	-$151.2K	-$196.1K	-$70.04K
YoY Change	10.19%		-100.0%	-121.58%	-22.92%	180.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Pretax Income	-$14.81M	-$3.570M	$18.92M	-$20.32M	-$17.56M	$1.532M	-$5.381M	-$1.464M	$98.22K	$0.00
YoY Change	314.86%	-118.87%	-193.11%	15.7%	-1246.24%	-128.47%	267.5%	-1590.81%
Income Tax	$19.74M	$14.90M	$4.396M	-$899.1K	-$582.9K	$582.9K		$0.00	$12.48K	$0.00
% Of Pretax Income			23.24%			38.05%			12.71%
Net Earnings	-$34.55M	-$18.47M	$14.52M	-$19.42M	-$16.98M	$948.9K	-$5.381M	-$1.464M	$85.75K	$0.00
YoY Change	87.08%	-227.2%	-174.78%	14.38%	-1888.95%	-117.63%	267.5%	-1807.6%
Net Earnings / Revenue	-20.03%	-11.59%	13.39%	-80.9%	-136.89%	10.05%	-152.46%	-231.89%	10.26%	0.0%
Basic Earnings Per Share	-$0.66	-$0.49	$0.17
Diluted Earnings Per Share	-$0.66	-$0.49	$143.2K	-$471.1K	-$503.1K	$34.17K	-$234.1K	-$143.2K	$8.656K	$0.00

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Short-Term Investments	$19.71M	$39.40M	$106.4M	$1.231M	$11.85M	$321.8K	$748.7K	$365.5K	$302.2K	$100.0K
YoY Change	-49.99%	-62.97%	8541.71%	-89.61%	3583.65%	-57.02%	104.84%	20.97%	202.15%
Cash & Equivalents	$19.25M	$38.95M	$106.4M	$1.231M	$11.85M	$321.8K	$748.7K	$351.5K	$262.2K	$100.0K
Short-Term Investments	$456.1K	$454.3K						$14.00K	$40.00K
Other Short-Term Assets	$3.914M	$5.293M	$2.523M	$345.8K	$1.856M	$50.82K	$42.82K	$27.48K	$38.72K
YoY Change	-26.06%	109.79%	629.72%	-81.37%	3551.69%	18.68%	55.82%	-29.03%
Inventory	$25.79M	$22.55M	$11.12M	$2.619M	$684.9K	$489.2K	$106.1K
Prepaid Expenses
Receivables	$4.261M	$4.472M	$3.867M	$1.351M	$386.0K	$1.306M	$487.1K	$25.00K	$83.74K
Other Receivables	$0.00	$11.94K	$0.00	$450.3K	$788.8K	$0.00	$0.00	$264.0K	$0.00
Total Short-Term Assets	$53.67M	$71.74M	$123.9M	$5.997M	$15.57M	$2.168M	$1.385M	$682.0K	$424.6K	$300.0K
YoY Change	-25.19%	-42.11%	1966.11%	-61.48%	618.23%	56.55%	103.03%	60.62%	41.54%
Property, Plant & Equipment	$65.35M	$45.29M	$18.77M	$5.164M	$299.0K	$94.64K	$150.1K	$42.13K	$48.12K
YoY Change	44.29%	141.35%	263.39%	1626.92%	215.96%	-36.93%	256.16%	-12.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.000M	$2.000M	$493.6K	$276.8K	$406.8K	$2.199M	$0.00
YoY Change	0.0%	305.23%	78.32%	-31.96%	-81.5%
Other Assets	$3.462M	$1.527M	$515.0K	$51.88K	$268.4K	$0.00	$14.50K
YoY Change	126.71%	196.58%	892.6%	-80.67%		-100.0%
Total Long-Term Assets	$304.5M	$251.1M	$161.1M	$64.69M	$16.66M	$16.05M	$9.748M	$45.83K	$52.36K	$0.00
YoY Change	21.23%	55.88%	149.08%	288.28%	3.77%	64.69%	21169.19%	-12.47%
Total Assets	$358.1M	$322.9M	$285.0M	$70.68M	$32.23M	$18.22M	$11.13M	$727.9K	$477.0K	$300.0K
YoY Change
Accounts Payable	$13.34M	$7.871M	$2.586M	$3.557M	$715.3K	$273.8K	$278.4K	$0.00	$8.720K	$0.00
YoY Change	69.5%	204.4%	-27.32%	397.32%	161.23%	-1.65%		-100.0%
Accrued Expenses	$9.797M	$8.073M	$301.3K	$1.155M	$714.2K	$291.1K	$56.50K	$180.00	$13.20K	$0.00
YoY Change	21.36%	2579.4%	-73.91%	61.7%	145.37%	415.19%	31288.89%	-98.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$134.5K	$5.000M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change		-100.0%	-97.31%
Long-Term Debt Due	$3.547M	$2.250M
YoY Change	57.64%
Total Short-Term Liabilities	$55.46M	$47.38M	$45.26M	$12.36M	$5.582M	$1.148M	$334.9K	$294.2K	$21.92K	$0.00
YoY Change	17.04%	4.68%	266.2%	121.44%	386.29%	242.72%	13.85%	1242.06%
Long-Term Debt	$153.3M	$125.5M	$97.48M	$13.90M	$0.00	$0.00	$58.28K	$810.0K	$0.00	$0.00
YoY Change	22.1%	28.76%	601.22%			-100.0%	-92.8%
Other Long-Term Liabilities	$30.13M	$17.31M	$8.715M	$2.646M	$66.80K	$0.00
YoY Change	74.04%	98.66%	229.43%	3860.48%
Total Long-Term Liabilities	$183.4M	$142.8M	$106.2M	$16.55M	$66.80K	$0.00	$58.28K	$810.0K	$0.00	$0.00
YoY Change	28.4%	34.5%	541.78%	24671.5%		-100.0%	-92.8%
Total Liabilities	$238.9M	$190.7M	$151.5M	$28.91M	$5.649M	$1.148M	$393.2K	$1.104M	$21.92K	$0.00
YoY Change	25.24%	25.92%	423.95%	411.76%	392.11%	191.92%	-64.39%	4937.32%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021
Basic Shares Outstanding	64.54M	53.64M	43.34M
Diluted Shares Outstanding	64.54M	53.64M	101.4M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $7.8248 Million

About Medicine Man Technologies, Inc.

Medicine Man Technologies, Inc. engages in the cultivation, manufacture, distribution, and retail sale of cannabis and cannabis related products. The company is headquartered in Denver, Colorado and currently employs 729 full-time employees. The company went IPO on 2015-12-23. The Company’s business involves the cultivation, manufacturing, distribution and retail sale of cannabis and cannabis-related products. The firm sells products it manufactures and cultivates and a variety of other cannabis goods through wholly owned retail stores, licensing arrangements, and/or third-party operators and retailers. The company has three segments: Retail, Wholesale and Other. The Retail segment consists of retail locations for the sale of cannabis products. The Wholesale segment consists of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products. The Other segment encompasses the Company’s general corporate operations, in-store advertisements and certain vendor promotions. The company has operations in Colorado and New Mexico. The firm owns and operates 63 retail dispensaries, six cultivation facilities and three manufacturing facilities.

Industry: Services-Management Consulting Services Peers: Aquestive Therapeutics, Inc. Clearside Biomedical, Inc. EYENOVIA, INC. Enliven Therapeutics, Inc. JOHNSON & JOHNSON OPIANT PHARMACEUTICALS, INC. Longboard Pharmaceuticals, Inc. Mystic Holdings Inc./NV Odonate Therapeutics, Inc.